equity investment

Clinical informatics startup Ovation looks to grow its business in laboratory information systems for precision molecular diagnostic labs.

Emedgene, which makes AI-based, automated genomic interpretation software, will use the Series A funding to expand its US sales operations.

The genome informatics company will apply the new capital to deploy the DNAnexus Apollo platform for multi-omics data science exploration, analysis, and discovery.

The firm said it raised €55.5 million to fund the expansion of its Idylla test platform, its sales and marketing activities, and other general corporate purposes.

The Belgium-based firm plans to use the proceeds to fund expansion of the Idylla test platform, sales and marketing activities, and additional general corporate purposes.

The Series E financing will go, in part, toward expansion of the company's US presence by growing its workforce and marketing to more American hospitals.

Foresite Capital and F-Prime Capital joined previous investors in this second Series B closing, bringing the total Series B value to £33 million.

Privately owned Oxford Nanopore offers a range of tools and and instruments based on a proprietary nanopore-based DNA and RNA sequencing technology.

Vertex Pharmaceuticals has invested £10.5 million in the British analytics company as the companies launch a multiyear R&D partnership seeking novel drug targets.